More Articles

Medical

Taking the plunge into digital

Andrew Stone, (Nov 13, 2019)

Medical affairs is starting to expand its knowledge, reach and engagement with digital tools
Access and Evidence

Putting a price on life: Is the answer outside pharma?

Nicola Davies, (Nov 4, 2019)

Gene replacement and cell-based therapies are here to cure, but are we ready for them? The current difficulty pricing groundbreaking healthcare advancements suggests maybe not.
Commercial

Breaking out of data silos in commercial

Ulrich Neumann, (Oct 21, 2019)

Pharma’s commercial teams have much to gain if they can overcome technical and cultural blockages that prevent data sharing
Patients and Medical

Empowering patients with the right data at the right time

Andrew Stone, (Oct 17, 2019)

Pharma is starting to exploit the potential of data from connected devices and smartphones to help patients better manage their conditions
Patients and Medical

Five shifts toward consumer-centric transformation

Jeff Gourdji, (Oct 14, 2019)

There's now a roadmap for pharma organisations seeking to become truly patient centred
Patients and Medical

Putting patients front and center

Andrew Stone, (Sep 20, 2019)

When it comes to access, pharma can only gain by starting with the patient, says Takeda’s Liz Lewis
Patients and Medical

Towards patient preferred trials

Katie Osborne, (Sep 18, 2019)

Putting the patient at the centre of clinical trials could be transformative
Patients and Medical

Design: Pharma’s next frontier

Lucy Fulford, (Sep 16, 2019)

Design Thinking and Human-Centric Design promise better outcomes and superior returns if Pharma can unlock its potential
Commercial

No patents. No launches. No stages. Welcome to modern pharma.

Paul Schrimpf, (Sep 3, 2019)

Winning in customer experience requires pharmaceutical companies to literally get off their own drugs, says Paul Schrimpf
Patients and Medical

Whose data is it anyway?

Andy stone, (Aug 30, 2019)

When cancer patient Pete started to look into who held records about his illness and treatment, mapping the journey of his data proved to be no easy feat.

Pages